| Watson Confirms Beyaz(R) Patent Challenge |
Bradenton Herald/PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to market ...
|
| Watson challenges patents on Bayer's Beyaz |
CNBC.comPARSIPPANY, NJ - Watson Pharmaceuticals Inc. said Friday it is challenging Bayer's patent on the birth control pill Beyaz. Watson said Bayer responded by filed a lawsuit accusing Watson of patent infringement. The Food and Drug Administration will not ...
|
| Watson Confirms Beyaz(R) Patent Challenge |
Sacramento Bee10, 2012 -- /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) seeking approval to ...
|
| Watson Settles Patent Dispute |
Daily Markets (blog)Watson Pharmaceuticals Inc. (NYSE:WPI) recently announced that it has reached a settlement with Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson (NYSE:JNJ), on a patent litigation related to Watson Pharma's generic version of Janssen's ...
|
| Watson Settles Patent Dispute |
NASDAQWatson Pharmaceuticals Inc. ( WPI ) recently announced that it has reached a settlement with Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson ( JNJ ), on a patent litigation related to Watson Pharma's generic version of Janssen's birth ...
|
| US HOT STOCKS: Watson Pharma and HomeStreet Active In Late Trading |
Wall Street JournalAmong the companies whose shares are actively trading in the after hours session are Watson Pharmaceuticals Inc. (WPI) and HomeStreet Inc. (HMST). Watson has filed an abbreviated new-drug application with the US Food and Drug Administration for its ...
|
| Watson Seeks FDA Approval For Generic Version Of Beyaz |
Wall Street JournalWatson Pharmaceuticals Inc. (WPI) has filed an abbreviated new-drug application with the US Food and Drug Administration for its generic version of Bayer HealthCare Pharmaceuticals Inc.'s Beyaz oral contraceptive. Bayer HealthCare, along with parent ...
|
